About Us

The Gamma Knife Charitable Fund

The Gamma Knife Charitable Fund (previously the Brain Met Fund)  is the charity wing of the Brain Centre Foundation. It was established in 2006 to sponsor patients in need for the treatment of Gamma Knife Radiosurgery to treat brain metastasis.

Brain metastasis is the most common tumour affecting the brain. In Hong Kong’s 7.5m population, an estimated 3000 patients will develop brain metastasis each year. Conventional treatment such as whole brain radiation therapy (WBRT) carries poor prognosis and risk of long term cognitive impairment. Gamma Knife Radiosurgery in one of the most effective treatment for brain metastasis and significantly improves survival and quality of life.

Apart from brain metastasis, the Gamma Knife Charitable Fund has now extended its sponsorship to include treatment of other tumours including Glioblastomas, Meningiomas, Acoustic Schwannomas, Pituitary adenomas and Arteriovenous malformations.

Our Vision

To make Gamma Knife the gold standard treatment for intracranial radiosurgery known and accessible to every citizen of Hong Kong. We envision a future where no patient is denied this life-saving and quality-of-life-enhancing treatment due to financial difficulties. Through our unwavering commitment, we aim to empower individuals facing the daunting diagnosis of a brain tumour, ensuring that they receive the best guidance, support and empathy.

Our Mission

We are committed to:


Championing the awareness and understanding of Gamma Knife as a superior treatment option for intracranial conditions through education and public outreach.


Removing financial barriers for those who cannot afford the treatment.


Partnering with healthcare institutions and medical professionals in the private and public sector, as well as the community to expand access to the Gamma Knife technology.


To empower patients and their families with knowledge and guidance to navigate the challenges of their diagnosis and treatment journey.

Research and Innovation

Supporting research initiatives and technological advancements in Gamma Knife radiosurgery to continually improve treatment outcomes.